BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 15083191)

  • 21. Microsatellite and chromosome instability in squamous cell laryngeal carcinoma.
    Sasiadek M; Stembalska-Kozlowska A; Smigiel R; Krecicki T; Blin N; Mirghomizadeh F
    Int J Oncol; 2001 Aug; 19(2):401-5. PubMed ID: 11445859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of p16INK4a alterations and 9p21 loss of heterozygosity in locally advanced laryngeal squamous cell carcinoma.
    Bazan V; Zanna I; Migliavacca M; Sanz-Casla MT; Maestro ML; Corsale S; Macaluso M; Dardanoni G; Restivo S; Quintela PL; Bernaldez R; Salerno S; Morello V; Tomasino RM; Gebbia N; Russo A
    J Cell Physiol; 2002 Sep; 192(3):286-93. PubMed ID: 12124774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Detailed mapping and clinical significance of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis].
    Xu XF; Tang PZ; Cheng SJ
    Ai Zheng; 2003 May; 22(5):452-7. PubMed ID: 12753701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p16 inactivation by methylation of the CDKN2A promoter occurs early during neoplastic progression in Barrett's esophagus.
    Bian YS; Osterheld MC; Fontolliet C; Bosman FT; Benhattar J
    Gastroenterology; 2002 Apr; 122(4):1113-21. PubMed ID: 11910361
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Loss of heterozygosity on chromosome 9p13-23 in microdissected laryngeal squamous cell carcinoma by microsatellite analysis].
    Xu X; An Q; Zhang J; Tang P; Cheng S
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2001 Oct; 36(5):367-71. PubMed ID: 12761947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microsatellite instability and MLH1 promoter methylation in human retinoblastoma.
    Choy KW; Pang CP; Fan DS; Lee TC; Wang JH; Abramson DH; Lo KW; To KF; Yu CB; Beaverson KL; Cheung KF; Lam DS
    Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3404-9. PubMed ID: 15452042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Loss of heterozygosity on chromosome 13 in squamous cell carcinomas of the larynx].
    Bai S; Zhang X; Wang J
    Zhonghua Zhong Liu Za Zhi; 1997 Jan; 19(1):35-7. PubMed ID: 10743052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutational Status of CDKN2A and TP53 Genes in Laryngeal Squamous Cell Carcinoma.
    Todorova TA; Jordanov SH; Stancheva GS; Chalakov IJ; Melnicharov MB; Kunev KV; Mitev VI; Kaneva RP; Goranova TE
    Pathol Oncol Res; 2015 Apr; 21(2):413-21. PubMed ID: 25149524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Densely methylated MLH1 promoter correlates with decreased mRNA expression in sporadic colorectal cancers.
    Furukawa T; Konishi F; Masubuchi S; Shitoh K; Nagai H; Tsukamoto T
    Genes Chromosomes Cancer; 2002 Sep; 35(1):1-10. PubMed ID: 12203784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of p16 expression and allelic imbalance / loss of heterozygosity of 9p21 in cutaneous squamous cell carcinomas.
    Gray SE; Kay E; Leader M; Mabruk M
    J Cell Mol Med; 2006; 10(3):778-88. PubMed ID: 16989737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Microsatellite instability and loss of heterozygosity of fragile histidine triad gene in laryngeal squamous cell carcinoma].
    Yin DT; Dong MM
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2005 Jan; 40(1):45-8. PubMed ID: 15906520
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modes of silencing of p16 in development of esophageal squamous cell carcinoma.
    Tokugawa T; Sugihara H; Tani T; Hattori T
    Cancer Res; 2002 Sep; 62(17):4938-44. PubMed ID: 12208744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detailed deletion mapping of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis.
    Xu XF; Gao YN; Cheng SJ
    Chin Med J (Engl); 2004 Aug; 117(8):1204-9. PubMed ID: 15361296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Homozygous deletion of p16 and p15 genes in laryngeal squamous cell carcinoma].
    Li F; Kang N; Li Y; He G; Lin C; Sun X; Gao H; Sun K
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Feb; 19(1):30-2. PubMed ID: 11836682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Msh2, Mlh1, Fhit, p53, Bcl-2, and Bax expression in invasive and in situ squamous cell carcinoma of the uterine cervix.
    Giarnieri E; Mancini R; Pisani T; Alderisio M; Vecchione A
    Clin Cancer Res; 2000 Sep; 6(9):3600-6. PubMed ID: 10999751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alterations of MLH1 and microsatellite instability in esophageal squamous cell carcinomas.
    Liu FX; Huang XP; Xu X; Cai Y; Han YL; Wu RL; Wu M; Zhan QM; Wang MR
    Yi Chuan Xue Bao; 2005 Mar; 32(3):234-42. PubMed ID: 15931783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic and protein markers related to laryngeal epithelial precursor lesions and their neoplastic progression.
    Álvarez-Marcos C; López F; Alonso-Guervós M; Domínguez F; Suárez C; Hermsen MA; Llorente JL
    Acta Otolaryngol; 2013 Mar; 133(3):281-90. PubMed ID: 23137024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Promoter hypermethylation of DNA repair genes MLH1 and MSH2 in adenocarcinomas and squamous cell carcinomas of the lung.
    Gomes A; Reis-Silva M; Alarcão A; Couceiro P; Sousa V; Carvalho L
    Rev Port Pneumol; 2014; 20(1):20-30. PubMed ID: 24360395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequent hypermethylation of MLH1 promoter in normal endometrium of patients with endometrial cancers.
    Kanaya T; Kyo S; Maida Y; Yatabe N; Tanaka M; Nakamura M; Inoue M
    Oncogene; 2003 Apr; 22(15):2352-60. PubMed ID: 12700670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Promoter methylation of MLH1, PMS2, MSH2 and p16 is a phenomenon of advanced-stage HCCs.
    Hinrichsen I; Kemp M; Peveling-Oberhag J; Passmann S; Plotz G; Zeuzem S; Brieger A
    PLoS One; 2014; 9(1):e84453. PubMed ID: 24400091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.